Sympatient

Impact-Beschreibung

Our story began in 2016, when our co-founder Julian Angern started researching VR-based anxiety therapy at the University Medical Center Schleswig-Holstein. Ever since we have been developing our treatments according to the highest standards in quality and efficacy. Our care offerings provide patients with the flexibility they need, while incorporating contacts to real therapists and doctors.
Impact-Statusmit Handelsregistereintrag
Impact-Datum2017
Impact-KategorieAusgründung
Ebene des ForschungsimpactsWirtschaftliche Umsetzung